The Therapeutic Brain Mapping and Neurotechnology (TBHN) working group is a working group where scientists from closely neighboring disciplines, especially neurology, psychiatry, engineering, biology and psychology, have come together since 2012 and transformed their academic knowledge into scientific studies. The working group includes studies investigating the basic functions of the nervous system and the changes that occur in disease states with brain imaging methods such as electroencephalogram, magnetic resonance imaging and functional magnetic resonance imaging, and investigates the unknowns of the brain in healthy and sick populations. In particular, the main goals of the group are to reveal neural biomarkers in various neuropsychiatric diseases and to reveal brain maps in healthy and sick people. Research studies, which started with computational methods such as machine learning and feature selection, continue today with deep learning-based models supported by artificial intelligence.
Our working group has published 81 publications in international peer-reviewed journals, 67 of which are within the scope of WOS, and our working group has been conducting academic collaborations with research centers and brain research communities such as The Society for Brain Mapping and Therapeutics (SBMT), American Psychiatric Association (APA), International Brain Research Consortium (IBRC), EEG and Clinical Neuroscience Society (ECNS), International Society For Neurofeedback & Research (ISNR).
Üsküdar University, which trains graduate and doctoral level researchers in the field of neuroscience in our country, carries out its studies in cognitive neuroscience, clinical neuroscience, neurobiofeedback, neurotechnology, bioinformatics laboratories and Biotechnology and Yazamer application and research centers with its researchers in the TBHN working group.
